TPG Group Holdings (SBS) Advisors, Inc. - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 130 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 7.84 and the average weighting 0.2%.

Quarter-by-quarter ownership
TPG Group Holdings (SBS) Advisors, Inc. ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$46,718,000
+220.5%
2,477,066
+100.0%
0.34%
+56.8%
Q2 2019$14,578,000
-13.8%
1,238,5330.0%0.22%
-33.7%
Q1 2019$16,906,000
+33.2%
1,238,5330.0%0.33%
+62.0%
Q4 2018$12,695,000
-38.4%
1,238,5330.0%0.20%
-21.8%
Q3 2018$20,622,000
+5.4%
1,238,5330.0%0.26%
+1.9%
Q2 2018$19,569,000
+24.4%
1,238,5330.0%0.26%
+8.4%
Q1 2018$15,729,000
+10.9%
1,238,5330.0%0.24%
+8.7%
Q4 2017$14,181,000
-6.5%
1,238,5330.0%0.22%
-11.4%
Q3 2017$15,172,000
+7.0%
1,238,5330.0%0.25%
+27.5%
Q2 2017$14,181,000
-45.0%
1,238,5330.0%0.19%
-37.9%
Q1 2017$25,761,0000.0%1,238,5330.0%0.31%
+11.9%
Q4 2016$25,761,000
-36.5%
1,238,5330.0%0.28%
-32.2%
Q3 2016$40,587,000
+31.2%
1,238,5330.0%0.41%
+20.9%
Q2 2016$30,926,000
+2.0%
1,238,5330.0%0.34%
+12.6%
Q1 2016$30,332,000
-25.9%
1,238,5330.0%0.30%
+1.7%
Q4 2015$40,909,000
+0.8%
1,238,5330.0%0.30%
+51.0%
Q3 2015$40,574,000
-38.2%
1,238,5330.0%0.20%
-35.3%
Q2 2015$65,605,000
-8.7%
1,238,533
-50.2%
0.30%
-16.5%
Q1 2015$71,819,0002,488,5330.36%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Novo Holdings A/S 6,402,366$128,496,0006.43%
Cormorant Asset Management, LP 150,000$3,011,0000.80%
PFM Health Sciences, LP 738,027$14,812,0000.30%
Partner Investment Management, L.P. 27,893$560,0000.11%
Spark Investment Management LLC 32,100$642,0000.10%
PointState Capital LP 275,000$5,519,0000.07%
DRIEHAUS CAPITAL MANAGEMENT LLC 97,809$1,963,0000.06%
CADIAN CAPITAL MANAGEMENT, LP 100,000$2,007,0000.06%
Nicholas Investment Partners, LP 50,456$1,013,0000.06%
Baker Brothers Advisors 153,350$3,078,0000.04%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders